For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Bucharest 73120

0 studies enrolling now · 49 studies all time

What they study most

Acute Coronary Syndrome, Alzheimer's Disease, Arthritis, Rheumatoid, Autoimmune Disease, Axial Spondyloarthritis, Cardiovascular Disease, Cardiovascular Diseases, Chronic Kidney Disease, Colles' Fracture, Colorectal Cancer, Connective Tissue Disease, Diabetes Mellitus, Type 1

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients — Stopped early
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of LY900014 in Participants With Type 1 Diabetes — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis — Completed
• A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) — Withdrawn before enrolling
• A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy — Completed
• A Study in Second Line Metastatic Colorectal Cancer — Completed
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis — Completed
• A Study for Participants With Small-Cell Lung Cancer — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• A Study for Participants With Major Depression — Completed
• A Study of LY2409021 in Patients With Type 2 Diabetes — Completed
• A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus — Completed
• A Study for Participants With Pancreatic Cancer — Completed
• A Study in Prevention of Re-emergence of Depression Symptoms — Completed
• A Study in Patients With Type 2 Diabetes Mellitus — Completed
• A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy — Completed
• Effect of Ruboxistaurin on Clinically Significant Macular Edema — Completed
• A Study in Patients With Rheumatoid Arthritis — Completed
• Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) — Completed
• Second Study of the Effect of Teriparatide on Hip Fracture Healing — Completed
• Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo — Completed
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) — Completed
• A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes — Completed
• A Study in Adults With Type 1 Diabetes — Completed
• Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes — Completed
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects — Completed
• A Long-Term Study in Schizophrenia — Stopped early
• A Study in the Treatment of Osteoarthritis Knee Pain — Completed
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia — Completed
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms — Completed
• Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder — Completed
• A Study for Patients With Type 2 Diabetes Mellitus — Completed
• A Study for Patients With Head and Neck Cancer — Completed
• A Study of Duloxetine in Patients With Osteoarthritis Knee Pain — Completed
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) — Completed
• Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes — Completed
• Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer — Completed
• Duloxetine Versus Placebo for Osteoarthritis Knee Pain — Completed
• Effects of Teriparatide on Distal Radius Fracture Healing — Completed